JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2051
Great Southern Bancorp
GSBC
$866M
| $7.35M | ﹤0.01% |
182,049
+39,653
| +28% | +$1.57M |
2013 Q2
28 quarters
|
|
2052
Fidelity National Financial
FNF
$10.5B
| $7.33M | ﹤0.01% |
248,798
-213,379
| -46% | -$5.87M |
2013 Q2
28 quarters
|
|
|
EVOP
2053
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $7.32M | ﹤0.01% |
320,675
-5,230
| -2% | -$104K |
2018 Q2
8 quarters
|
|
|
ILPT
2054
Industrial Logistics Properties Trust
ILPT
$475M
| $7.32M | ﹤0.01% |
356,007
-67,897
| -16% | -$1.25M |
2018 Q1
9 quarters
|
|
2055
Inseego
INSG
$81.2M
| $7.31M | ﹤0.01% |
63,054
+15,432
| +32% | +$1.63M |
2016 Q4
14 quarters
|
|
|
ESPR
2056
DELISTED
Esperion Therapeutics
ESPR
| $7.3M | ﹤0.01% |
142,321
+6,760
| +5% | +$283K |
2015 Q3
19 quarters
|
|
2057
Surgery Partners
SGRY
$1.75B
| $7.3M | ﹤0.01% |
631,272
-185,868
| -23% | -$2.04M |
2016 Q4
14 quarters
|
|
2058
Jacobs Solutions
J
$16.2B
| $7.29M | ﹤0.01% |
103,907
+16,737
| +19% | +$1.13M |
2013 Q2
28 quarters
|
|
2059
Evertec
EVTC
$1.74B
| $7.27M | ﹤0.01% |
258,880
+80,102
| +45% | +$2.12M |
2013 Q2
28 quarters
|
|
2060
Qualys
QLYS
$6.87B
| $7.24M | ﹤0.01% |
69,619
+14,220
| +26% | +$1.49M |
2014 Q2
24 quarters
|
|
2061
PUT
Dollar General
DG
$26.3B
| $7.24M | ﹤0.01% |
+38,000
| New | +$6.88M |
2020 Q2
0 quarters
|
|
2062
Jones Lang LaSalle
JLL
$13.9B
| $7.23M | ﹤0.01% |
69,904
-7,260
| -9% | -$748K |
2013 Q2
28 quarters
|
|
2063
Icon
ICLR
$13B
| $7.23M | ﹤0.01% |
42,914
-47,721
| -53% | -$7.52M |
2014 Q4
22 quarters
|
|
2064
PUT
Okta
OKTA
$38.2B
| $7.23M | ﹤0.01% |
+36,100
| New | +$6.13M |
2020 Q2
0 quarters
|
|
2065
Strategic Education
STRA
$1.76B
| $7.23M | ﹤0.01% |
47,031
-3,981
| -8% | -$621K |
2013 Q2
28 quarters
|
|
2066
1st Source
SRCE
$2.08B
| $7.22M | ﹤0.01% |
202,818
-36,742
| -15% | -$1.22M |
2013 Q2
28 quarters
|
|
2067
PUT
WisdomTree US Total Dividend Fund
DTD
$1.64B
| $7.21M | ﹤0.01% |
720,000
| – | – |
2018 Q4
6 quarters
|
|
2068
iShares Core S&P US Growth ETF
IUSG
$34.8B
| $7.2M | ﹤0.01% |
100,135
+59,059
| +144% | +$3.92M |
2016 Q1
17 quarters
|
|
2069
CALL
Zoetis
ZTS
$29.5B
| $7.2M | ﹤0.01% |
52,500
| – | – |
2017 Q1
13 quarters
|
|
|
2070
PUT
Zoetis
ZTS
$29.5B
| $7.2M | ﹤0.01% |
52,500
-42,000
| -44% | -$5.48M |
2017 Q4
10 quarters
|
|
2071
Plug Power
PLUG
$2.64B
| $7.17M | ﹤0.01% |
873,652
+713,665
| +446% | +$3.34M |
2017 Q3
11 quarters
|
|
2072
CALL
Editas Medicine
EDIT
$428M
| $7.16M | ﹤0.01% |
242,000
-73,800
| -23% | -$1.93M |
2019 Q4
2 quarters
|
|
2073
MACOM Technology Solutions
MTSI
$25.1B
| $7.15M | ﹤0.01% |
208,284
-401,191
| -66% | -$11.7M |
2014 Q1
25 quarters
|
|
2074
A.O. Smith
AOS
$7.74B
| $7.14M | ﹤0.01% |
151,451
+24,408
| +19% | +$1.07M |
2013 Q2
28 quarters
|
|
2075
CALL
KKR & Co
KKR
$80.8B
| $7.14M | ﹤0.01% |
231,100
+54,500
| +31% | +$1.46M |
2018 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.